Charles River Laboratories International Inc.

11/20/2024 | News release | Distributed by Public on 11/20/2024 10:31

Advancing Therapeutic Delivery in CNS Diseases

Our alliance with Insightec, a global healthcare company committed to using focused ultrasound technology to transform patient care, will provide our clients access to a comprehensive global service technology platform for the application of focused ultrasound (FUS) in drug discovery and preclinical development of neuroscience therapies.

This partnership aims to advance novel therapeutic applications across multiple neurologic conditions and represents a significant step forward in advancing research in Central Nervous System (CNS) diseases.

The integration of FUS technology into our preclinical services will enhance the precision and effectiveness of therapeutic delivery strategies, allowing us to refine our use of research models and support the discovery of novel medicines.

Read the Press Release